Use of this site is subject to, and your continued use constitutes your express agreement to be
bound by, the
Terms of Use and
Privacy Statement.
Any unauthorized use of this site is strictly prohibited.

XBRL Voluntary Filing Program
Visit the CSA’s XBRL website for information about XBRL and the voluntary program.Click here for information about XBRL software and viewing XBRL financial statements.

Pender NDI Life Sciences Fund (VCC) Inc.

Mailing Address:

1280 - 885 West Georgia StreetVancouver, British ColumbiaV6C 3E8

Head Office Address:

1280 - 885 West Georgia StreetVancouver, British ColumbiaV6E 3E8

Contact Name:

Tanner Philp

Principal Regulator:

British Columbia

Business e-mail address:

tphilp@lionscapital.com

Short Form Prospectus Issuer:

No

Telephone Number:

604 688-6877

Reporting Jurisdictions:

British Columbia

Fax Number:

Stock Exchange:

N/A

Date of Formation:

Jul 16 2003

Stock Symbol:

Jurisdiction Where Formed:

British Columbia

Auditor:

Ernst & Young LLP

Industry Classification:

financial services - investment companies and funds

General Partner:

CUSIP Number:

Transfer Agent:

The Investment Administration Solution Inc.

Financial Year-End:

Dec 31

Size of Issuer (Assets):

Under $5,000,000

Use of this site is subject to, and your continued use constitutes your express agreement to be
bound by, the
Terms of Use and
Privacy Statement.
Any unauthorized use of this site is strictly prohibited.

XBRL Voluntary Filing Program
Visit the CSA’s XBRL website for information about XBRL and the voluntary program.Click here for information about XBRL software and viewing XBRL financial statements.